Find verified Amifampridine phosphate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Amifampridine phosphate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Amifampridine phosphate API.
Alternate Names: Zenas, 3,4-DAPP, Firdapse (TN)
CAS No: 446254-47-3
PubChem CID: 9920716
Mol Formula: C5H10N3O4P
Mol Weight: 207.12 g/mol
IUPAC Name: phosphoric acid;pyridine-3,4-diamine
Commercial / Development Status: Commercial APIs
Source / Manufacturing Origin: Synthetic APIs
API Description: Amifampridine phosphate is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for lambert-eaton myasthenic syndrome and myasthenia gravis and has 4 investigational indications. 4-Aminopyridine derivative that acts as a potassium channel blocker to increase release of acetylcholine from nerve terminals. It is used in the treatment of congenital myasthenic syndromes.
